The human bile salt export pump: characterization of substrate specificity and identification of inhibitors. 2002

Jane A Byrne, and Sandra S Strautnieks, and Giorgina Mieli-Vergani, and Christopher F Higgins, and Kenneth J Linton, and Richard J Thompson
Institute of Liver Studies, King's College Hospital, Guy's, King's, and St. Thomas' School of Medicine, London, England.

OBJECTIVE The bile salt export pump (BSEP) is the major bile salt transporter in the liver canalicular membrane. Our aim was to determine the affinity of the human BSEP for bile salts and identify inhibitors. METHODS Human BSEP was expressed in insect cells. Adenosine triphosphatase (ATPase) assays were performed, and bile salt transport studies were undertaken. RESULTS The BSEP gene, ABCB11, was cloned and a recombinant baculovirus was generated. Infected insect cells expressed a 140-kilodalton protein that was absent in uninfected and in mock-infected cells. An ATPase assay showed BSEP to have a high basal ATPase activity. Transport assays were used to determine the Michaelis constant for taurocholate as 4.25 micromol/L, with a maximum velocity of 200 pmol x min(-1) x mg(-1) protein. Inhibition constant values for other bile salts were 11 micromol/L for glycocholate, 7 micromol/L for glycochenodeoxycholate, and 28 micromol/L for taurochenodeoxycholate. Cyclosporin A, rifampicin, and glibenclamide were proved to be competitive inhibitors of BSEP taurocholate transport, with inhibition constant values of 9.5 micromol/L, 31 micromol/L, and 27.5 micromol/L, respectively. Progesterone and tamoxifen did not inhibit BSEP. CONCLUSIONS The human BSEP is a high-affinity bile salt transporter. The relative affinities for the major bile salts differ from those seen in rodents and reflect the different bile salt pools. BSEP is competitively inhibited by therapeutic drugs. This is a potentially significant mechanism for drug-induced cholestasis.

UI MeSH Term Description Entries
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005905 Glyburide An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide Glibenclamide,Daonil,Diabeta,Euglucon 5,Euglucon N,Glybenclamide,HB-419,HB-420,Maninil,Micronase,Neogluconin,HB 419,HB 420,HB419,HB420
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000074020 ATP Binding Cassette Transporter, Subfamily B, Member 11 ATP-binding cassette, subfamily B, protein (P-glycoproteins) that functions in the ATP-dependent secretion of BILE SALTS into the BILE CANALICULI of HEPATOCYTES. Mutations in the ABCB11 gene are associated with progressive familial intrahepatic cholestasis 2 (see CHOLESTASIS, INTRAHEPATIC). ABCB11 Protein,ATP Binding Cassette Subfamily B Member 11,ATP Binding Cassette Transporter, Sub-Family B, Member 11,BSEP Protein,Bile Salt Export Pump
D000251 Adenosine Triphosphatases A group of enzymes which catalyze the hydrolysis of ATP. The hydrolysis reaction is usually coupled with another function such as transporting Ca(2+) across a membrane. These enzymes may be dependent on Ca(2+), Mg(2+), anions, H+, or DNA. ATPases,Adenosinetriphosphatase,ATPase,ATPase, DNA-Dependent,Adenosine Triphosphatase,DNA-Dependent ATPase,DNA-Dependent Adenosinetriphosphatases,ATPase, DNA Dependent,Adenosinetriphosphatases, DNA-Dependent,DNA Dependent ATPase,DNA Dependent Adenosinetriphosphatases,Triphosphatase, Adenosine
D001647 Bile Acids and Salts Steroid acids and salts. The primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine. The secondary bile acids are further modified by bacteria in the intestine. They play an important role in the digestion and absorption of fat. They have also been used pharmacologically, especially in the treatment of gallstones. Bile Acid,Bile Salt,Bile Salts,Bile Acids,Acid, Bile,Acids, Bile,Salt, Bile,Salts, Bile
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin

Related Publications

Jane A Byrne, and Sandra S Strautnieks, and Giorgina Mieli-Vergani, and Christopher F Higgins, and Kenneth J Linton, and Richard J Thompson
February 2007, Pflugers Archiv : European journal of physiology,
Jane A Byrne, and Sandra S Strautnieks, and Giorgina Mieli-Vergani, and Christopher F Higgins, and Kenneth J Linton, and Richard J Thompson
January 2000, Gene,
Jane A Byrne, and Sandra S Strautnieks, and Giorgina Mieli-Vergani, and Christopher F Higgins, and Kenneth J Linton, and Richard J Thompson
January 2007, HPB : the official journal of the International Hepato Pancreato Biliary Association,
Jane A Byrne, and Sandra S Strautnieks, and Giorgina Mieli-Vergani, and Christopher F Higgins, and Kenneth J Linton, and Richard J Thompson
January 2017, Molecular bioSystems,
Jane A Byrne, and Sandra S Strautnieks, and Giorgina Mieli-Vergani, and Christopher F Higgins, and Kenneth J Linton, and Richard J Thompson
January 2010, Pharmacogenetics and genomics,
Jane A Byrne, and Sandra S Strautnieks, and Giorgina Mieli-Vergani, and Christopher F Higgins, and Kenneth J Linton, and Richard J Thompson
May 2001, Hepatology (Baltimore, Md.),
Jane A Byrne, and Sandra S Strautnieks, and Giorgina Mieli-Vergani, and Christopher F Higgins, and Kenneth J Linton, and Richard J Thompson
August 2005, The Journal of pharmacology and experimental therapeutics,
Jane A Byrne, and Sandra S Strautnieks, and Giorgina Mieli-Vergani, and Christopher F Higgins, and Kenneth J Linton, and Richard J Thompson
December 2013, Toxicological sciences : an official journal of the Society of Toxicology,
Jane A Byrne, and Sandra S Strautnieks, and Giorgina Mieli-Vergani, and Christopher F Higgins, and Kenneth J Linton, and Richard J Thompson
November 2002, Gastroenterology,
Jane A Byrne, and Sandra S Strautnieks, and Giorgina Mieli-Vergani, and Christopher F Higgins, and Kenneth J Linton, and Richard J Thompson
November 2002, Gastroenterology,
Copied contents to your clipboard!